CA2269971A1 - Derives de pyrimidine - Google Patents

Derives de pyrimidine Download PDF

Info

Publication number
CA2269971A1
CA2269971A1 CA002269971A CA2269971A CA2269971A1 CA 2269971 A1 CA2269971 A1 CA 2269971A1 CA 002269971 A CA002269971 A CA 002269971A CA 2269971 A CA2269971 A CA 2269971A CA 2269971 A1 CA2269971 A1 CA 2269971A1
Authority
CA
Canada
Prior art keywords
compound
formula
pharmaceutically acceptable
group
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002269971A
Other languages
English (en)
Inventor
Trent Lee Abraham
Boris Arnoldovich Czeskis
Minxia He
Lisa Ann Shipley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2269971A1 publication Critical patent/CA2269971A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

La présente invention se rapporte à des dérivés de pyrimidine, à des procédés de préparation de ces dérivés et à des intermédiaires utiles à leur préparation, à des compositions pharmaceutiques contenant de tels dérivés et à leurs utilisations en tant que médicaments.
CA002269971A 1997-09-03 1998-09-03 Derives de pyrimidine Abandoned CA2269971A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5747297P 1997-09-03 1997-09-03
US60/057,472 1997-09-03
PCT/US1998/018381 WO1999011269A1 (fr) 1997-09-03 1998-09-03 Derives de pyrimidine

Publications (1)

Publication Number Publication Date
CA2269971A1 true CA2269971A1 (fr) 1999-03-11

Family

ID=22010758

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002269971A Abandoned CA2269971A1 (fr) 1997-09-03 1998-09-03 Derives de pyrimidine

Country Status (4)

Country Link
EP (1) EP0954316A4 (fr)
AU (1) AU9302298A (fr)
CA (1) CA2269971A1 (fr)
WO (1) WO1999011269A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323570A (en) * 1978-11-15 1982-04-06 Beiersdorf Aktiengesellschaft Substituted aminopyrimidines
MA18829A1 (fr) * 1979-05-18 1980-12-31 Ciba Geigy Ag Derives de la pyrimidine,procedes pour leur preparation,compositions pharmaceutiques contenant ces composes et leur utilisation therapeutique

Also Published As

Publication number Publication date
AU9302298A (en) 1999-03-22
EP0954316A1 (fr) 1999-11-10
EP0954316A4 (fr) 2002-02-13
WO1999011269A1 (fr) 1999-03-11

Similar Documents

Publication Publication Date Title
JP3447292B2 (ja) イミダゾピリジン及び胃腸の疾病の治療のためのその使用
EP0887344B1 (fr) Quinoléines et Quinazolines utiles en thérapeutique
CZ180195A3 (en) Azetinediones being substituted by spirocycloalkyl group, their use and process of their preparation, pharmaceutical composition containing such substituted azetinediones, process of its preparation and a composition in which said preparation is comprised
JPH0649027A (ja) インドール誘導体
CZ26396A3 (en) Novel perhydroisoindole derivatives, process of their preparation and pharmaceutical compositions containing thereof
AU724473B2 (en) Tetrahydroquinoline derivatives as EAA antagonists
CZ325797A3 (cs) Arylglycinamidové deriváty, způsob výroby a farmaceutický prostředek s jejich obsahem
JPH06293741A (ja) 複素環置換フエニルシクロヘキサンカルボン酸誘導体
KR101112515B1 (ko) 이미다졸-5- 카복실산 유도체의 염 및 그 제조방법 및 상기 염으로 구성되는 약학 조성물
FR2687676A1 (fr) Nouveaux derives de polyazaindenes antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.
EP0781276B1 (fr) Derives de pyrimidinone
US20030045525A1 (en) Quinoline and quinazoline compounds useful in therapy
CA2438813C (fr) Derives d'acide alcoxycarbonylaminoheteroaryle carboxylique en tant qu'antagonistes d'ip
JPH02286677A (ja) テトラゾール置換ピペラジン化合物および該化合物を含有する医薬製剤
JPH0789957A (ja) ビフェニルメチルアミン誘導体
JPH0748369A (ja) 置換モノピリジルメチルおよびビピリジルメチル誘導体
CA2269971A1 (fr) Derives de pyrimidine
KR870001168B1 (ko) 이소인돌 유도체의 제조방법
JPH06271573A (ja) イミダゾリル置換フエニル酢酸プロリンアミド類
FR2687677A1 (fr) Nouveaux derives de polyazaindenes antagonistes des recepteurs a l'angiotensine ii ; leurs procedes de preparation, compositions pharmaceutiques les contenant.
JPH0665209A (ja) イミダゾリル置換フエニルプロピオン酸および桂皮酸誘導体
JP2003119181A (ja) インテグリンと受容体との結合を阻害するカルボン酸誘導体
AP899A (en) Indole derivatives useful in therapy.
RU2140924C1 (ru) Производные пиридо(1,2,3-de)хиноксалина, способы их получения, лекарственное средство
JPS6130588A (ja) ベンゾ〔c〕〔1,8〕ナフチリジン、その製造方法及びその使用、並びにこれらの化合物を含有する調製剤

Legal Events

Date Code Title Description
FZDE Discontinued